These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9685931)

  • 1. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins.
    Bernkop-Schnürch A
    J Control Release; 1998 Mar; 52(1-2):1-16. PubMed ID: 9685931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan and its derivatives: potential excipients for peroral peptide delivery systems.
    Bernkop-Schnürch A
    Int J Pharm; 2000 Jan; 194(1):1-13. PubMed ID: 10601680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract.
    Lehr CM
    Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):119-60. PubMed ID: 7600586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro evaluation of chitosan-EDTA-protease-inhibitor conjugates which might be useful in oral delivery of peptides and proteins.
    Bernkop-Schnürch A; Scerbe-Saiko A
    Pharm Res; 1998 Feb; 15(2):263-9. PubMed ID: 9523313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemically modified chitosans as enzyme inhibitors.
    Bernkop-Schnürch A; Kast CE
    Adv Drug Deliv Rev; 2001 Nov; 52(2):127-37. PubMed ID: 11718936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery.
    Leonaviciute G; Bernkop-Schnürch A
    Expert Opin Drug Deliv; 2015; 12(11):1703-16. PubMed ID: 26477549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro.
    Marschütz MK; Bernkop-Schnürch A
    Biomaterials; 2000 Jul; 21(14):1499-507. PubMed ID: 10872779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional Delivery Systems for Advanced oral Uptake of Peptide/Protein Drugs.
    Park JW; Kim SJ; Kwag DS; Kim S; Park J; Youn YS; Bae YH; Lee ES
    Curr Pharm Des; 2015; 21(22):3097-110. PubMed ID: 26027575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Improvement of drug bioavailability using protease inhibitors].
    Zhaopeng H; Kimura G; Yoshikawa Y; Takada K
    Nihon Rinsho; 1998 Mar; 56(3):595-600. PubMed ID: 9549342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional matrices for oral peptide delivery.
    Bernkop-Schnürch A; Walker G
    Crit Rev Ther Drug Carrier Syst; 2001; 18(5):459-501. PubMed ID: 11763498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presystemic metabolism of orally administered peptide drugs and strategies to overcome it.
    Bernkop-Schnürch A; Schmitz T
    Curr Drug Metab; 2007 Jun; 8(5):509-17. PubMed ID: 17584022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic barriers for GI peptide and protein delivery.
    Woodley JF
    Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):61-95. PubMed ID: 7600588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in protein and peptide drug delivery systems.
    Malik DK; Baboota S; Ahuja A; Hasan S; Ali J
    Curr Drug Deliv; 2007 Apr; 4(2):141-51. PubMed ID: 17456033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic barrier of the lower intestinal tract of salmon to the oral delivery of protein and peptide drugs.
    Ledger R; Tucker IG; Walker GF
    J Control Release; 2002 Dec; 85(1-3):91-103. PubMed ID: 12480315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging trends in oral delivery of peptide and protein drugs.
    Mahato RI; Narang AS; Thoma L; Miller DD
    Crit Rev Ther Drug Carrier Syst; 2003; 20(2-3):153-214. PubMed ID: 14584523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and evaluation of a chitosan-aprotinin conjugate for the peroral delivery of therapeutic peptides and proteins susceptible to enzymatic degradation.
    Werle M; Loretz B; Entstrasser D; Föger F
    J Drug Target; 2007 Jun; 15(5):327-33. PubMed ID: 17541841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improvement of intestinal absorption of peptide and protein drugs by chemical modification with fatty acids].
    Yamamoto A
    Nihon Rinsho; 1998 Mar; 56(3):601-7. PubMed ID: 9549343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery.
    Chopra S; Mahdi S; Kaur J; Iqbal Z; Talegaonkar S; Ahmad FJ
    J Pharm Pharmacol; 2006 Aug; 58(8):1021-32. PubMed ID: 16872548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug metabolism in the nasal mucosa.
    Sarkar MA
    Pharm Res; 1992 Jan; 9(1):1-9. PubMed ID: 1589391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.